3065 related articles for article (PubMed ID: 14688154)
1. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).
Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group
Hum Reprod; 2004 Jan; 19(1):41-7. PubMed ID: 14688154
[TBL] [Abstract][Full Text] [Related]
2. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.
Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group
Fertil Steril; 2004 Jan; 81(1):19-25. PubMed ID: 14711538
[TBL] [Abstract][Full Text] [Related]
3. Reconciling the definitions of polycystic ovary syndrome: the ovarian follicle number and serum anti-Müllerian hormone concentrations aggregate with the markers of hyperandrogenism.
Dewailly D; Pigny P; Soudan B; Catteau-Jonard S; Decanter C; Poncelet E; Duhamel A
J Clin Endocrinol Metab; 2010 Sep; 95(9):4399-405. PubMed ID: 20610596
[TBL] [Abstract][Full Text] [Related]
4. Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature.
Azziz R
J Clin Endocrinol Metab; 2006 Mar; 91(3):781-5. PubMed ID: 16418211
[TBL] [Abstract][Full Text] [Related]
5. Best methods for identification and treatment of PCOS.
Artini PG; Di Berardino OM; Simi G; Papini F; Ruggiero M; Monteleone P; Cela V
Minerva Ginecol; 2010 Feb; 62(1):33-48. PubMed ID: 20186113
[TBL] [Abstract][Full Text] [Related]
6. [Preliminary study on the value of ratio of serum luteinizing hormone/follicle-stimulating hormone in diagnosis of polycystic ovarian syndrome among women with polycystic ovary].
Ma CS; Lin Y; Zhang CH; Xu H; Li YF; Zhang SC; Tan Y; Quan S; Xing FQ
Zhonghua Fu Chan Ke Za Zhi; 2011 Mar; 46(3):177-80. PubMed ID: 21575449
[TBL] [Abstract][Full Text] [Related]
7. Clinical and metabolic characteristics of Turkish adolescents with polycystic ovary syndrome.
Ates S; Aydın S; Ozcan P; Soyman Z; Gokmen Karasu AF; Sevket O
J Obstet Gynaecol; 2018 Feb; 38(2):236-240. PubMed ID: 28920502
[TBL] [Abstract][Full Text] [Related]
8. Polycystic ovary syndrome: reviewing diagnosis and management of metabolic disturbances.
Spritzer PM
Arq Bras Endocrinol Metabol; 2014 Mar; 58(2):182-7. PubMed ID: 24830595
[TBL] [Abstract][Full Text] [Related]
9. Women with oligo-/amenorrhoea and polycystic ovaries have identical responses to GnRH stimulation regardless of their androgen status: comparison of the Rotterdam and Androgen Excess Society diagnostic criteria.
Lewandowski KC; Cajdler-Luba A; Bieńkiewicz M; Lewiński A
Neuro Endocrinol Lett; 2011; 32(6):847-56. PubMed ID: 22286802
[TBL] [Abstract][Full Text] [Related]
10. Polycystic Ovary Syndrome in Adolescents.
Witchel SF; Roumimper H; Oberfield S
Endocrinol Metab Clin North Am; 2016 Jun; 45(2):329-44. PubMed ID: 27241968
[TBL] [Abstract][Full Text] [Related]
11. Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models.
Caldwell AS; Middleton LJ; Jimenez M; Desai R; McMahon AC; Allan CM; Handelsman DJ; Walters KA
Endocrinology; 2014 Aug; 155(8):3146-59. PubMed ID: 24877633
[TBL] [Abstract][Full Text] [Related]
12. The evaluation of metabolic parameters and insulin sensitivity for a more robust diagnosis of the polycystic ovary syndrome.
Amato MC; Galluzzo A; Finocchiaro S; Criscimanna A; Giordano C
Clin Endocrinol (Oxf); 2008 Jul; 69(1):52-60. PubMed ID: 18034780
[TBL] [Abstract][Full Text] [Related]
13. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
Hassa H; Tanir HM; Yildiz Z
Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
[TBL] [Abstract][Full Text] [Related]
14. High Prevalence of Polycystic Ovary Syndrome in Type 1 Diabetes Mellitus Adolescents: Is There a Difference Depending on the NIH and Rotterdam Criteria?
Busiah K; Colmenares A; Bidet M; Tubiana-Rufi N; Levy-Marchal C; Delcroix C; Jacquin P; Martin D; Benadjaoud L; Jacqz-Aigrain E; Laborde K; Robert JJ; Samara-Boustani D; Polak M
Horm Res Paediatr; 2017; 87(5):333-341. PubMed ID: 28437788
[TBL] [Abstract][Full Text] [Related]
15. New approach to polycystic ovary syndrome and other forms of anovulatory infertility.
Laven JS; Imani B; Eijkemans MJ; Fauser BC
Obstet Gynecol Surv; 2002 Nov; 57(11):755-67. PubMed ID: 12447098
[TBL] [Abstract][Full Text] [Related]
16. History of discovery of polycystic ovary syndrome.
Adv Clin Exp Med; 2017; 26(3):555-558. PubMed ID: 28791833
[TBL] [Abstract][Full Text] [Related]
17. Implications of the 2014 Androgen Excess and Polycystic Ovary Syndrome Society guidelines on polycystic ovarian morphology for polycystic ovary syndrome diagnosis.
Christ JP; Gunning MN; Fauser BCJM
Reprod Biomed Online; 2017 Oct; 35(4):480-483. PubMed ID: 28733169
[TBL] [Abstract][Full Text] [Related]
18. Polycystic ovary syndrome in adolescents.
Dabadghao P
Best Pract Res Clin Endocrinol Metab; 2019 Jun; 33(3):101272. PubMed ID: 31027973
[TBL] [Abstract][Full Text] [Related]
19. Effects of the insulin sensitizer pioglitazone on menstrual irregularity, insulin resistance and hyperandrogenism in young women with polycystic ovary syndrome.
Stabile G; Borrielli I; Artenisio AC; Bruno LM; Benvenga S; Giunta L; La Marca A; Volpe A; Pizzo A
J Pediatr Adolesc Gynecol; 2014 Jun; 27(3):177-82. PubMed ID: 24814528
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic criteria for polycystic ovarian syndrome.
Broekmans FJ; Fauser BC
Endocrine; 2006 Aug; 30(1):3-11. PubMed ID: 17185786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
